Provided is a pharmaceutical composition for use in the treatment of flushing associated with carcinoid tumors and carcinoid syndrome in a patient in need thereof, which composition comprises an alpha adrenergic receptor agonist, pharmaceutically acceptable salt thereof, or combinations thereof; and a pharmaceutically acceptable carrier, wherein said composition is to be topically applied to the site of the flushing.